Impact of the ABCD‐GENE score on clopidogrel clinical effectiveness after PCI: a multi‐site, real‐world investigation

CD Thomas, F Franchi, EC Keeley… - Clinical …, 2022 - Wiley Online Library
The Age, Body mass index, Chronic kidney disease, Diabetes mellitus, and CYP2C19
GENEtic variants (ABCD‐GENE) score was developed to identify patients at risk for …
被引用次数：10 相关文章

Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation.

CD Thomas, F Franchi, EC Keeley… - Clinical …, 2022 - europepmc.org
The ABCD-GENE score was developed to identify patients at risk for diminished antiplatelet
effects with clopidogrel after percutaneous coronary intervention (PCI) and utilizes Age …

Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation

CD Thomas, F Franchi, EC Keeley… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
The Age, Body mass index, Chronic kidney disease, Diabetes mellitus, and CYP2C19
GENEtic variants (ABCD-GENE) score was developed to identify patients at risk for …

Impact of the ABCD‐GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi‐Site, Real‐World Investigation

CD Thomas, F Franchi, EC Keeley, JS Rossi… - Clinical Pharmacology …, 2022 - cir.nii.ac.jp
抄録< jats: p> The< jats: bold> A</jats: bold> ge,< jats: bold> B</jats: bold> ody mass
index,< jats: bold> C</jats: bold> hronic kidney disease,< jats: bold> D</jats: bold> iabetes …
[HTML] nih.gov

[HTML][HTML] Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-site, Real-world Investigation

CD Thomas, F Franchi, EC Keeley… - Clinical …, 2022 - ncbi.nlm.nih.gov
The ABCD-GENE score was developed to identify patients at risk for diminished antiplatelet
effects with clopidogrel after percutaneous coronary intervention (PCI) and utilizes Age …